Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-05-24
2011-05-24
Davis, Zinna N (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S337000, C546S113000, C546S278100
Reexamination Certificate
active
07947705
ABSTRACT:
The invention relates to substituted 7-azaindoles, process for their preparation, pharmaceutical preparations which comprise these compounds, and the pharmaceutical use of these compounds, which are inhibitors of phosphodiesterase 4, as active ingredients for the treatment of disorders which can be influenced by inhibition of phosphodiesterase 4 activity in particular in immunocompetent cells (e.g. macrophages and lymphocytes) by the compounds of the invention.
REFERENCES:
patent: 5712298 (1998-01-01), Amschler
patent: 6008231 (1999-12-01), Lebaut et al.
patent: 6169090 (2001-01-01), Dyke et al.
patent: 6251923 (2001-06-01), Hofgen et al.
patent: 6344467 (2002-02-01), Lebaut et al.
patent: 6656959 (2003-12-01), Freyne et al.
patent: 7211583 (2007-05-01), Hofgen
patent: 2002/0111351 (2002-08-01), Hofgen et al.
patent: 2002/0115651 (2002-08-01), Hofgen et al.
patent: 2002/0119971 (2002-08-01), Hofgen et al.
patent: 2002/0119982 (2002-08-01), Wang et al.
patent: 2002/0137745 (2002-09-01), Hofgen et al.
patent: 2002/0161025 (2002-10-01), Lebaut et al.
patent: 2003/0134876 (2003-07-01), Hofgen et al.
patent: 2003/0207892 (2003-11-01), Lebaut et al.
patent: 2004/0106641 (2004-06-01), Hofgen et al.
patent: 748403 (1999-11-01), None
patent: 2 270 301 (2006-08-01), None
patent: 198 18 964 (1999-11-01), None
patent: WO 95/01338 (1995-01-01), None
patent: WO 96/11929 (1996-04-01), None
patent: WO 98/09946 (1998-03-01), None
patent: WO 99/50262 (1999-10-01), None
patent: WO 99/64423 (1999-12-01), None
patent: WO 00/26208 (2000-05-01), None
patent: WO 01/90076 (2001-11-01), None
patent: WO 02/34747 (2002-05-01), None
Garattini “Active Drug Metabolites”,Clinical Pharm., (1985) 10, pp. 216-227.
Hatzelmann, et al. “Anti-Inflammatory and Immunomodulatory Potential of the Novel PDE4 Inhibitor Roflumilast in Vitro”,J. Exp. Pharm., (2001) 297, pp. 267-279.
Hulme, et al, “Orally Active indoleN-Oxide PDE4 Inhibitors”, Bioorganic and Medicinal Chem. Letters, (1998) 8, pp. 3053-3058.
Sinhababu, et al. “Review of prodrugs of anticancer agents”, Advanced Drug Delivery Reviewes, 19 (1996), pp. 241-273.
Egerland Ute
Höfgen Norbert
Kuss Hildegard
Olbrich Matthias
Rundfeldt Chris
Biotie Therapies GmbH
Davis Zinna N
Fulbright & Jaworski L.L.P.
LandOfFree
7-azaindoles and the use thereof as therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 7-azaindoles and the use thereof as therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7-azaindoles and the use thereof as therapeutic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2645851